[Ip-health] Note on use of Orphan Drug Act to increase price of hydroxyprogesterone caproate from $10 to $1, 500 per dose
Mary Carol Jennings
marycaroljennings at gmail.com
Tue Mar 22 19:56:40 PDT 2011
Thank you all for working on this - as an OB/Gyn it absolutely affects my
high-risk patients. Many of the health statuses that come with low
socioeconomic status are associated with premature birth. And low SES is
also associated, in this country, with poor quality health insurance - or
lack of health insurance. So many of the patients who get this drug today in
the US will not be able to get it.
And as others have noted, premature babies are a big problem for a lot of
players - families, social support networks, and even governments and
taxpayers, who pick up the bills involved in their care.
- Mary Carol
On Tue, Mar 22, 2011 at 7:39 AM, Jamie Love <james.love at keionline.org>wrote:
> This concerns an increase in the price of hydroxyprogesterone
> caproate, from $10 to $20 per dose to $1,500 per dose. Long used off
> label to prevent premature births, the drug will be sold by KV
> Pharmaceuticals, under a new legal monopoly, at 150 times the price of
> the generic product. using the trade name Makena.
> Following a letter from U.S. Sen. Sherrod Brown (D-OH) and U.S. Sen.
> Amy Klobuchar (D-MN) to the FTC, there have been news reports about
> the price hike, including by Bloomberg, Time, TechDirt, the WSJ, the
> LA Times, ABC and the Associated Press, as well as many other news
> The KEI note below provides links to news stories and a copy of
> Senator Sherrod Brown's press release, as well as details of the legal
> mechanism that created the monopoly (the Orphan Drug Act), and data
> from ClinicialTrials.Gov and the NIH RePORTER database regarding the
> relative roles of the KV Pharmaceuticals and other parties, including
> the NIH, in funding and carrying out research on hydroxyprogesterone
> Note on use of Orphan Drug Act to increase price of
> hydroxyprogesterone caproate from $10 to $1,500 per dose
> James Love. Knowledge Ecology International
> http://www.keionline.org, +1.202.332.2670, US Mobile: +1.202.361.3040,
> Geneva Mobile: +41.76.413.6584, efax: +1.888.245.3140.
> Ip-health mailing list
> Ip-health at lists.keionline.org
Mary Carol Jennings
Boston University Medical Center
More information about the Ip-health